Inhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Beijing Nova Program (Z20110006820003)
- China National Funds for Distinguished Young Scientists (82125004)
- Fuwai Hospital, Chinese Academy of Medical Sciences
- Fundamental Research Funds for the Central Universities
- Beijing Municipal Commission of Education (KJZD20191002301)
- National Natural Science Foundation of China (81900335)
This publication has 74 references indexed in Scilit:
- NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid ArthritisScience Translational Medicine, 2013
- Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined ImmunosuppressionCirculation: Heart Failure, 2013
- NR4A1 (Nur77) Deletion Polarizes Macrophages Toward an Inflammatory Phenotype and Increases AtherosclerosisCirculation Research, 2012
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular trapsJournal of Experimental Medicine, 2010
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunityNature, 2010
- SEURAT: Visual analytics for the integrated analysis of microarray dataBMC Medical Genomics, 2010
- Interleukin-1α stimulates proinflammatory cytokine expression in human cardiac myofibroblastsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Usefulness of Immunosuppression for Giant Cell MyocarditisThe American Journal of Cardiology, 2008
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentNew England Journal of Medicine, 1997
- Immunohistochemical characterization of infiltrating mononuclea cells in the rat heart with experimental autoimmune giant cell myocarditisClinical and Experimental Immunology, 1992